Pyxis Oncology (PYXS) Earnings Date & Reports

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYXS is expected to report earnings to fall 30.28% to -27 cents per share on November 17

Pyxis Oncology PYXS Stock Earnings Reports

Q3'26

Est.

$-0.28

Q2'26

Missed

by $0.04

Q1'26

Est.

$-0.37

Q4'25

Missed

by $0.95

Q3'25

Missed

by $0.01

The last earnings report on August 13 showed earnings per share of -40 cents, missing the estimate of -36 cents. With 1.20M shares outstanding, the current market capitalization sits at 241.88M.

View a ticker or compare two or three

PYXS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for PYXS